Skip to main content

Table 2 Clinical characteristics of CHB patients

From: Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patients

 

Total (n = 53)

HBeAg+ (n = 33)

HBeAg (n = 20)

Male, n (%)

34 (64.15%)

21 (63.63%)

13 (65.00%)

Age (years)

37.62 ± 9.38

35.12 ± 8.94

41.75 ± 8.79

ALT (IU/L)

44.94 ± 23.90

46.06 ± 21.45

43.10 ± 27.99

AST (IU/L)

35.06 ± 15.11

35.38 ± 13.69

34.70 ± 17.52

HBV DNA (log10IU/mL)

5.63 ± 1.97

6.54 ± 1.74

4.14 ± 1.36

HBsAg (IU/mL)

12,838 ± 24,624

20,157 ± 29,156

1047 ± 1443

HBeAg (S/CO)

/

689 ± 623

/

  1. Data was expressed as mean ± standard deviation